[1]
Alexis, A., Anders, K., Seetasith, A. and Holden, M. 2023. Comparison of Study Designs for Primary Phase III Trials for Omalizumab Versus Dupilumab for Patients With Chronic Spontaneous Urticaria. SKIN The Journal of Cutaneous Medicine. 7, 6 (Nov. 2023), s299. DOI:https://doi.org/10.25251/skin.7.supp.299.